{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:28:51Z","timestamp":1787063331420,"version":"build-2736575974"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T00:00:00Z","timestamp":1556236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.00877","type":"journal-article","created":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T09:40:29Z","timestamp":1556271629000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":102,"title":["Endometrial Tumor Microenvironment Alters Human NK Cell Recruitment, and Resident NK Cell Phenotype and Function"],"prefix":"10.3389","volume":"10","author":[{"given":"Clara","family":"Degos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mellie","family":"Heinemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Barrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Boucherit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Lambaudie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Savina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Gorvel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Olive","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,4,26]]},"reference":[{"key":"B1","first-page":"1531","article-title":"Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review","volume":"11","author":"Kaaks","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/S0140-6736(15)00130-0","article-title":"Endometrial cancer","volume":"387","author":"Morice","year":"2016","journal-title":"Lancet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/0090-8258(83)90111-7","article-title":"Two pathogenetic types of endometrial carcinoma","volume":"15","author":"Bokhman","year":"1983","journal-title":"Gynecol Oncol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1200\/JCO.2012.48.2596","article-title":"Type I and II endometrial cancers: have they different risk factors?","volume":"31","author":"Setiawan","year":"2013","journal-title":"J Clin Oncol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ijgo.2014.02.003","article-title":"FIGO staging for carcinoma of the vulva, cervix, and corpus uteri","volume":"125","author":"Oncology","year":"2014","journal-title":"Int J Gynaecol Obstet."},{"key":"B6","doi-asserted-by":"publisher","first-page":"4450","DOI":"10.1158\/1078-0432.CCR-0732-3","article-title":"Intratumoral CD8+ T lymphocytes as a prognostic factor of survival in endometrial carcinoma","volume":"10","author":"Kondratiev","year":"2004","journal-title":"Clin Cancer Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejca.2016.02.026","article-title":"CD103 defines intraepithelial CD8+ PD1+ tumour-infiltrating lymphocytes of prognostic significance in endometrial adenocarcinoma","volume":"60","author":"Workel","year":"2016","journal-title":"Eur J Cancer."},{"key":"B8","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Kandoth","year":"2013","journal-title":"Nature."},{"key":"B9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ygyno.2015.04.027","article-title":"Polymerase epsilon (POLE) ultra-mutated tumors induce robust tumor-specific CD4+ T cell responses in endometrial cancer patients","volume":"138","author":"Bellone","year":"2015","journal-title":"Gynecol Oncol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.ygyno.2016.11.023","article-title":"Polymerase epsilon (POLE) ultra-mutation in uterine tumors correlates with T lymphocyte infiltration and increased resistance to platinum-based chemotherapy in vitro","volume":"144","author":"Bellone","year":"2017","journal-title":"Gynecol Oncol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/nri1199","article-title":"Roles of the NKG2D immunoreceptor and its ligands","volume":"3","author":"Raulet","year":"2003","journal-title":"Nat Rev Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/sj.emboj.7600019","article-title":"Unravelling natural killer cell function: triggering and inhibitory human NK receptors","volume":"23","author":"Moretta","year":"2004","journal-title":"EMBO J."},{"key":"B13","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1146\/annurev.immunol.23.021704.115526","article-title":"NK cell recognition","volume":"23","author":"Lanier","year":"2005","journal-title":"Annu Rev Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.cyto.2006.08.006","article-title":"IL-18 acts synergistically with IL-15 in stimulating natural killer cell proliferation","volume":"35","author":"French","year":"2006","journal-title":"Cytokine."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.4049\/jimmunol.181.3.1627","article-title":"Cutting edge: Priming of NK cells by IL-18","volume":"181","author":"Chaix","year":"2008","journal-title":"J Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.it.2013.01.003","article-title":"Activating natural cytotoxicity receptors of natural killer cells in cancer and infection","volume":"34","author":"Koch","year":"2013","journal-title":"Trends Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"ra19","DOI":"10.1126\/scisignal.aad1884","article-title":"TGF-beta inhibits the activation and functions of NK cells by repressing the mTOR pathway","volume":"9","author":"Viel","year":"2016","journal-title":"Sci Signal."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.4049\/jimmunol.1601477","article-title":"Dendritic Cell-Derived IL-32alpha: a novel inhibitory cytokine of NK cell function","volume":"199","author":"Gorvel","year":"2017","journal-title":"J Immunol."},{"key":"B19","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1002\/(SICI)1097-0142(19970615)79:12<2320::AID-CNCR5>3.0.CO;2-P","article-title":"The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma","volume":"79","author":"Coca","year":"1997","journal-title":"Cancer."},{"key":"B20","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.molimm.2004.07.039","article-title":"Natural killer cells infiltrating colorectal cancer and MHC class I expression","volume":"42","author":"Sandel","year":"2005","journal-title":"Mol Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1111\/j.1600-0463.2009.02547.x","article-title":"Decrease in intrahepatic CD56+ lymphocytes in gastric and colorectal cancer patients with liver metastases","volume":"117","author":"Gulubova","year":"2009","journal-title":"APMIS."},{"key":"B22","doi-asserted-by":"publisher","first-page":"4120","DOI":"10.1073\/pnas.0730640100","article-title":"Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells","volume":"100","author":"Castriconi","year":"2003","journal-title":"Proc Natl Acad Sci USA."},{"key":"B23","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1007\/s00432-018-2635-3","article-title":"Role of natural killer cells in lung cancer","volume":"144","author":"Aktas","year":"2018","journal-title":"J Cancer Res Clin Oncol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"3609","DOI":"10.1172\/JCI45816","article-title":"Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity","volume":"121","author":"Mamessier","year":"2011","journal-title":"J Clin Invest."},{"key":"B25","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1002\/art.39295","article-title":"Inhibition of natural killer cell cytotoxicity by interleukin-6: implications for the pathogenesis of macrophage activation syndrome","volume":"67","author":"Cifaldi","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/1878-0261.12135","article-title":"Inhibition of IL-6-JAK\/Stat3 signaling in castration-resistant prostate cancer cells enhances the NK cell-mediated cytotoxicity via alteration of PD-L1\/NKG2D ligand levels","volume":"12","author":"Xu","year":"2018","journal-title":"Mol Oncol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.0105-2896.2010.00908.x","article-title":"Cytotoxic and non-cytotoxic roles of the CTL\/NK protease granzyme-B","volume":"235","author":"Afonina","year":"2010","journal-title":"Immunol Rev."},{"key":"B28","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/nprot.2009.7","article-title":"The role of IFN-gamma Elispot assay in HIV vaccine research","volume":"4","author":"Streeck","year":"2009","journal-title":"Nat Protocol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"5428","DOI":"10.1158\/0008-5472.CAN-12-1181","article-title":"Melanoma cells inhibit NK cell functions","volume":"72","author":"Sconocchia","year":"2012","journal-title":"Cancer Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3389\/fimmu.2016.00413","article-title":"Phenotypic and functional dysregulated blood NK cells in colorectal cancer patients can be activated by cetuximab plus IL-2 or IL-15","volume":"7","author":"Rocca","year":"2016","journal-title":"Front Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"605","DOI":"10.3389\/fimmu.2015.00605","article-title":"Natural killer cell-based therapies targeting cancer: possible strategies to gain and sustain anti-tumor activity","volume":"6","author":"Dahlberg","year":"2015","journal-title":"Front Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/ni.3518","article-title":"Targeting natural killer cells in cancer immunotherapy","volume":"17","author":"Guillerey","year":"2016","journal-title":"Nat Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/82_2015_446","article-title":"NK cells and cancer immunoediting","volume":"395","author":"Guillerey","year":"2016","journal-title":"Curr Top Microbiol Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"18538","DOI":"10.1073\/pnas.0509182102","article-title":"Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+\/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer","volume":"102","author":"Sato","year":"2005","journal-title":"Proc Natl Acad Sci USA."},{"key":"B35","doi-asserted-by":"publisher","first-page":"R48","DOI":"10.1186\/bcr3148","article-title":"CD8+ lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer","volume":"14","author":"Liu","year":"2012","journal-title":"Breast Cancer Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1097\/IGC.0000000000000482","article-title":"Intratumoral CD8+ lymphocyte infiltration as a prognostic factor and its relationship with cyclooxygenase 2 expression and microsatellite instability in endometrial cancer","volume":"25","author":"Suemori","year":"2015","journal-title":"Int J Gynecol Cancer."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1182\/blood-2004-09-3458","article-title":"NK cells that are activated by CXCL10 can kill dormant tumor cells that resist CTL-mediated lysis and can express B7-H1 that stimulates T cells","volume":"105","author":"Saudemont","year":"2005","journal-title":"Blood."},{"key":"B38","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1161\/CIRCRESAHA.108.192179","article-title":"CXCL10 inhibits viral replication through recruitment of natural killer cells in coxsackievirus B3-induced myocarditis","volume":"104","author":"Yuan","year":"2009","journal-title":"Circ Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nri.2017.49","article-title":"Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy","volume":"17","author":"Nagarsheth","year":"2017","journal-title":"Nat Rev Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1007\/BF02979055","article-title":"Protective antitumor activity through dendritic cell immunization is mediated by NK cell as well as CTL activation","volume":"22","author":"Kim","year":"1999","journal-title":"Arch Pharm Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1189\/jlb.71.2.173","article-title":"Role of chemokines in the biology of natural killer cells","volume":"71","author":"Robertson","year":"2002","journal-title":"J Leukoc Biol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"631","DOI":"10.3892\/ijo.30.3.631","article-title":"CCL21 induces extensive intratumoral immune cell infiltration and specific anti-tumor cellular immunity","volume":"30","author":"Turnquist","year":"2007","journal-title":"Int J Oncol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/35065016","article-title":"Involvement of chemokine receptors in breast cancer metastasis","volume":"410","author":"Muller","year":"2001","journal-title":"Nature."},{"key":"B44","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nri3049","article-title":"Homeostatic chemokine receptors and organ-specific metastasis","volume":"11","author":"Zlotnik","year":"2011","journal-title":"Nat Rev Immunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"a016295","DOI":"10.1101\/cshperspect.a016295","article-title":"IL-6 in inflammation, immunity, and disease","volume":"6","author":"Tanaka","year":"2014","journal-title":"Cold Spring Harb Perspect Biol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0092-8674(00)81959-5","article-title":"Stat3 as an oncogene","volume":"98","author":"Bromberg","year":"1999","journal-title":"Cell."},{"key":"B47","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.immuni.2004.07.020","article-title":"TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling","volume":"21","author":"Becker","year":"2004","journal-title":"Immunity."},{"key":"B48","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.smim.2014.01.008","article-title":"The two faces of IL-6 in the tumor microenvironment","volume":"26","author":"Fisher","year":"2014","journal-title":"Semin Immunol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","article-title":"Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer","volume":"15","author":"Johnson","year":"2018","journal-title":"Nat Rev Clin Oncol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1073\/pnas.0437939100","article-title":"IL-1 is required for tumor invasiveness and angiogenesis","volume":"100","author":"Voronov","year":"2003","journal-title":"Proc Natl Acad Sci USA."},{"key":"B51","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1479-5876-4-48","article-title":"Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment","volume":"4","author":"Lewis","year":"2006","journal-title":"J Transl Med."},{"key":"B52","doi-asserted-by":"publisher","first-page":"5529","DOI":"10.1167\/iovs.10-6331","article-title":"Effects of interleukin-1 receptor antagonist on tumor stroma in experimental uveal melanoma","volume":"52","author":"Triozzi","year":"2011","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B53","doi-asserted-by":"publisher","first-page":"e1039763","DOI":"10.1080\/2162402X.2015.1039763","article-title":"Interleukin-1 is required for cancer eradication mediated by tumor-specific Th1 cells","volume":"5","author":"Haabeth","year":"2016","journal-title":"Oncoimmunology."},{"key":"B54","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.immuni.2016.05.001","article-title":"Lag-3, Tim-3, and TIGIT: Co-inhibitory receptors with specialized functions in immune regulation","volume":"44","author":"Anderson","year":"2016","journal-title":"Immunity."},{"key":"B55","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1158\/0008-5472.CAN-13-1303","article-title":"Mature cytotoxic CD56(bright)\/CD16(+) natural killer cells can infiltrate lymph nodes adjacent to metastatic melanoma","volume":"74","author":"Messaoudene","year":"2014","journal-title":"Cancer Res."},{"key":"B56","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1158\/2326-6066.CIR-13-0171","article-title":"Reversal of NK-cell exhaustion in advanced melanoma by Tim-3 blockade","volume":"2","author":"Da Silva","year":"2014","journal-title":"Cancer Immunol Res."},{"key":"B57","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/s41590-018-0132-0","article-title":"Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity","volume":"19","author":"Zhang","year":"2018","journal-title":"Nat Immunol."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00877\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T09:40:34Z","timestamp":1556271634000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00877\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,26]]},"references-count":57,"alternative-id":["10.3389\/fimmu.2019.00877"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.00877","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,26]]},"article-number":"877"}}